Search
Sol Gel Technologies Ltd
SLGLAdd to Watchlist
82.250USD
-2.940-3.45%
Close 07-31 16:00（ET）Quotes delayed by 15 min
268.87MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Sol Gel Technologies Ltd is 8.00, ranking 171 out of 385 in the Biotechnology & Medical Research industry. The average price target is 50.00, with a high of 50.00 and a low of 50.00.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
193.000
Target Price
+134.65%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Sol Gel Technologies Ltd
SLGL
4
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Sol Gel Technologies Ltd's expected revenue for the next quarter?
Sol Gel Technologies Ltd's expected revenue is 600.00K.
What is Sol Gel Technologies Ltd's price target?
Analysts forecast that Sol Gel Technologies Ltd's price target is USD 50.00, with the highest forecast at USD 50.00 and the lowest forecast at USD 50.00.
How have Sol Gel Technologies LtdSLGL's recent earnings per share performed?
The market expectation was USD -1.31, while Sol Gel Technologies LtdSLGL's earnings per share (EPS) for the previous quarter was USD -1.07. EPS for the next quarter is expected at USD -2.57.
What is the analyst rating for Sol Gel Technologies Ltd?
Based on the ratings of Sol Gel Technologies Ltd's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.